{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:12:55Z","timestamp":1792699975687,"version":"4.5.0"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"national institute of mental health","doi-asserted-by":"publisher","award":["P30MH058107-23S2"],"award-info":[{"award-number":["P30MH058107-23S2"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collected qualitative data from 18 consumers and 23 clinical and non-clinical stakeholders to catalog anticipated individual-consumer, healthcare system, and structural levels barriers and facilitators to LAI ART implementation in Los Angeles County, California. Thematic analysis was guided by the CFIR implementation science model. CFIR constructs of intervention characteristics, individual characteristics, outer and inner setting, intervention characteristics, and implementation process emerged in analysis. Under intervention characteristics, anticipated facilitators included the relative advantage of LAI ART over pills for adherence and reduced treatment management burden and related anxiety; anticipated barriers included non-adherence to injection appointments, concerns of developing HIV resistance, discomfort with injection and cost. Anticipated facilitators based on individual characteristics included overall acceptability based on knowledge and positive beliefs about LAI ART. Participant noted several characteristics of the outer setting that could negatively impact implementation, such as medical mistrust, external policies, and LAI ART eligibility (i.e., to be virally suppressed prior to initiation). Participants were optimistic about the potential to decrease stigma but expressed that provider willingness for adoption could be hindered by challenges in organizational inner setting related to payment authorizations, increased staffing needs, medication procurement and storage, and provider and healthcare system readiness. Results from this pre-implementation study may inform rollout and scale-up of LAI ART in Los Angeles County.<\/jats:p>","DOI":"10.1371\/journal.pone.0262926","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T18:45:24Z","timestamp":1643913924000},"page":"e0262926","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-0177","authenticated-orcid":true,"given":"Oluwadamilola","family":"Jolayemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Bogart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik D.","family":"Storholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-3564","authenticated-orcid":true,"given":"David","family":"Goodman-Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rosenberg-Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyen","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Shoptaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael J.","family":"Landovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"pone.0262926.ref001","author":"A Dailey","year":"2018","journal-title":"HIV Surveillance Report 2018"},{"key":"pone.0262926.ref002","unstructured":"Ferrer B, Gunzenhauser JD, P\u00e9rez MJ, Solis HL, Ridley-Thomas M, Kuehl S, et al. HIV Surveillance Annual Report 2019 [Internet]. Los Angeles; 2020 [cited 2020 Oct 21]. Available from: http:\/\/publichealth.lacounty.gov\/dhsp"},{"key":"pone.0262926.ref003","unstructured":"Map-AIDSVu. Rates of Persons Living with HIV, 2018 [Internet]. 2020 [cited 2020 Oct 18]. Available from: http:\/\/map.aidsvu.org\/map?state=RI"},{"key":"pone.0262926.ref004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/COH.0000000000000165","article-title":"Current state and limitations of daily oral therapy for treatment","volume":"10","author":"DA Solomon","year":"2015","journal-title":"Current Opinion in HIV and AIDS"},{"key":"pone.0262926.ref005","unstructured":"LACounty.HIV\u2014Los Angeles County HIV\/AIDS Strategy [Internet]. [cited 2020 Oct 17]. Available from: https:\/\/www.lacounty.hiv\/"},{"issue":"2","key":"pone.0262926.ref006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/QAI.0b013e31802c2f51","article-title":"Psychiatric Illness and Virologic Response in Patients Initiating Highly Active Antiretroviral Therapy","volume":"44","author":"BW Pence","year":"2007","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"pone.0262926.ref007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11606-012-2176-4","article-title":"Food insecurity is associated with greater acute care utilization among hiv-infected homeless and marginally housed individuals in san francisco","volume":"28","author":"SD Weiser","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"1","key":"pone.0262926.ref008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2325957416667488","article-title":"Understanding Determinants of Racial and Ethnic Disparities in Viral Load Suppression: A Data Mining Approach","volume":"16","author":"DJ Feller","year":"2017","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"3","key":"pone.0262926.ref009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11524-011-9562-9","article-title":"Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users","volume":"88","author":"A Palepu","year":"2011","journal-title":"J Urban Heal"},{"issue":"1","key":"pone.0262926.ref010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2015.302905","article-title":"Housing status, medical care, and health outcomes among people living with HIV\/AIDS: A systematic review","volume":"106","author":"AA Aidala","year":"2016","journal-title":"Am J Public Health"},{"issue":"8","key":"pone.0262926.ref011","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s10461-020-02805-5","article-title":"Social and Structural Factors Associated with Sustained Viral Suppression Among Heterosexual Black Men with Diagnosed HIV in the United States, 2015\u20132017.","volume":"24","author":"DH McCree","year":"2020","journal-title":"AIDS Behav"},{"key":"pone.0262926.ref012","article-title":"Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis","volume":"16","author":"IT Katz","year":"2013","journal-title":"Journal of the International AIDS Society"},{"issue":"12","key":"pone.0262926.ref013","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMoa1904398","article-title":"Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression","volume":"382","author":"S Swindells","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0262926.ref014","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection","volume":"382","author":"C Orkin","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0262926.ref015","unstructured":"US Food and Drug and Drug Administration. FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV | FDA. [cited 2021 Jul 21]; Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-extended-release-injectable-drug-regimen-adults-living-hiv"},{"issue":"3","key":"pone.0262926.ref016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ptdy.2021.02.007","article-title":"FDA approves first once-monthly injectable drug regimen for adults with HIV","volume":"27","author":"CA Young","year":"2021","journal-title":"Pharm Today"},{"key":"pone.0262926.ref017","first-page":"179","article-title":"Evaluating cabotegravir\/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential","volume":"11","author":"C Fernandez","year":"2019","journal-title":"HIV AIDS (Auckl)"},{"key":"pone.0262926.ref018","article-title":"Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks.","author":"M Murray","year":"2020","journal-title":"AIDS Behav"},{"key":"pone.0262926.ref019","article-title":"Use of Injectable CAB\/RPV LA as Replacement ART in Virally Suppressed Adults With HIV","author":"E DeHaan","year":"2021","journal-title":"Use Inject CAB\/RPV LA as Replace ART Virally Suppressed Adults With HIV"},{"key":"pone.0262926.ref020","unstructured":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents-A Working Group of the Office of AIDS Research Advisory Council (OARAC) How to Cite the. [cited 2021 Nov 16]; Available from: http:\/\/hivinfo.nih.gov"},{"issue":"11","key":"pone.0262926.ref021","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1016\/S2352-3018(21)00184-3","article-title":"Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study","volume":"8","author":"C Orkin","year":"2021","journal-title":"lancet HIV"},{"key":"pone.0262926.ref022","unstructured":"ViiV Healthcare announces European Commission Decision for Vocabria (cabotegravir) and Rekambys (rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV [Internet]. [cited 2021 Nov 16]. Available from: https:\/\/viivhealthcare.com\/en-gb\/media\/press-releases\/2021\/october\/viiv-healthcare-announces-european-commission-decision\/"},{"issue":"3","key":"pone.0262926.ref023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/apc.2018.0198","article-title":"Long-acting injectable antiretroviral treatment acceptability and preferences: A qualitative study among US providers, adults living with HIV, and parents of youth living with HIV","volume":"33","author":"JM Simoni","year":"2019","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"pone.0262926.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190487","article-title":"Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain.","volume":"13","author":"D Kerrigan","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"pone.0262926.ref025","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s10461-017-2017-x","article-title":"Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States","volume":"22","author":"D Kerrigan","year":"2018","journal-title":"AIDS Behav"},{"issue":"12","key":"pone.0262926.ref026","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1007\/s10461-020-02918-x","article-title":"Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials","volume":"24","author":"A Mantsios","year":"2020","journal-title":"AIDS Behav"},{"issue":"1","key":"pone.0262926.ref027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/apc.2020.0164","article-title":"A Qualitative Exploration of Women\u2019s Interest in Long-Acting Injectable Antiretroviral Therapy across Six Cities in the Women\u2019s Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use","volume":"35","author":"MM Philbin","year":"2021","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"pone.0262926.ref028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0000000000002337","article-title":"Multisite Study of Women Living With HIV\u2019s Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy","volume":"84","author":"MM Philbin","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"pone.0262926.ref029","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12913-021-06214-9","article-title":"Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials","volume":"21","author":"A Mantsios","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"pone.0262926.ref030","first-page":"1532","article-title":"Effects of perceived racism, cultural mistrust and trust in providers on satisfaction with care","volume":"98","author":"R Benkert","year":"2006","journal-title":"J Natl Med Assoc"},{"issue":"S2","key":"pone.0262926.ref031","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/1475-6773.13220","article-title":"Discrimination in the United States: Experiences of black Americans","volume":"54","author":"SN Bleich","year":"2019","journal-title":"Health Serv Res"},{"issue":"2","key":"pone.0262926.ref032","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/08964289.2019.1585324","article-title":"HIV-Related Medical Mistrust, HIV Testing, and HIV Risk in the National Survey on HIV in the Black Community","volume":"45","author":"LM Bogart","year":"2019","journal-title":"Behav Med"},{"key":"pone.0262926.ref033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-030-48744-7_12","volume-title":"HIV in US Communities of Color","author":"LM Bogart","year":"2021"},{"issue":"10","key":"pone.0262926.ref034","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s10461-019-02464-1","article-title":"Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load","volume":"23","author":"AM Brincks","year":"2019","journal-title":"AIDS Behav"},{"issue":"2","key":"pone.0262926.ref035","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.2105\/AJPH.2014.302322","article-title":"The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men","volume":"105","author":"LA Eaton","year":"2015","journal-title":"Am J Public Health"},{"issue":"1","key":"pone.0262926.ref036","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10464-009-9280-6","article-title":"Psychosocial correlates of medical mistrust among African American men","volume":"45","author":"WP Hammond","year":"2010","journal-title":"Am J Community Psychol"},{"key":"pone.0262926.ref037","first-page":"79","volume-title":"Behavioral Medicine","author":"J Jaiswal","year":"2019"},{"issue":"10267","key":"pone.0262926.ref038","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0140-6736(20)32666-0","article-title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study","volume":"396","author":"ET Overton","year":"2021","journal-title":"Lancet (London, England)"},{"key":"pone.0262926.ref039","volume-title":"Implementation Science","author":"SA Birken","year":"2017"},{"key":"pone.0262926.ref040","unstructured":"Constructs\u2013The Consolidated Framework for Implementation Research [Internet]. [cited 2021 Apr 30]. Available from: https:\/\/cfirguide.org\/constructs\/"},{"issue":"1","key":"pone.0262926.ref041","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-017-0550-7","article-title":"Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: A rapid-cycle evaluation approach to improving implementation","volume":"12","author":"RE Keith","year":"2017","journal-title":"Implement Sci"},{"key":"pone.0262926.ref042","article-title":"Anal cancer screening among women with HIV: provider experiences and system-level challenges","author":"RT Higashi","year":"2021","journal-title":"AIDS Care\u2014Psychol Socio-Medical Asp AIDS\/HIV"},{"issue":"1","key":"pone.0262926.ref043","doi-asserted-by":"crossref","DOI":"10.1186\/s43058-020-00033-5","article-title":"Exploring barriers and facilitators to integrated hypertension-HIV management in Ugandan HIV clinics using the Consolidated Framework for Implementation Research (CFIR)","volume":"1","author":"M Muddu","year":"2020","journal-title":"Implement Sci Commun"},{"key":"pone.0262926.ref044","volume-title":"Qualitative data analysis: An expanded sourcebook","author":"M Miles","year":"1994","edition":"2"},{"key":"pone.0262926.ref045","volume-title":"Data management and analysis methods","author":"G Ryan","year":"2000"},{"issue":"4","key":"pone.0262926.ref046","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1525\/maq.1990.4.4.02a00020","article-title":"A Systematic Approach for Using Qualitative Methods in Primary Prevention Research","volume":"4","author":"DG Willms","year":"1990","journal-title":"Med Anthropol Q"},{"key":"pone.0262926.ref047","unstructured":"Self-efficacy\u2013The Consolidated Framework for Implementation Research [Internet]. [cited 2021 Jul 13]. Available from: https:\/\/cfirguide.org\/constructs\/self-efficacy\/"},{"issue":"6","key":"pone.0262926.ref048","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/tbm\/ibz085","article-title":"Using the Practical, Robust Implementation and Sustainability Model (PRISM) to qualitatively assess multilevel contextual factors to help plan, implement, evaluate, and disseminate health services programs","volume":"9","author":"MS McCreight","year":"2019","journal-title":"Transl Behav Med"},{"key":"pone.0262926.ref049","volume":"34","author":"AC Feldstein","year":"2008","journal-title":"The Joint Commission Journal on Quality and Patient Safety A Practical, Robust Implementation and Sustainability Model (PRISM) for Integrating Research Findings into Practice Research Methods"},{"issue":"2","key":"pone.0262926.ref050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152611795589663","article-title":"HIV treatment adherence, drug resistance, virologic failure: evolving concepts","volume":"11","author":"JB Nachega","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"pone.0262926.ref051","first-page":"844","volume-title":"JAMA\u2014Journal of the American Medical Association","author":"AS Fauci","year":"2019"},{"issue":"6","key":"pone.0262926.ref052","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1521\/aeap.2014.26.6.521","article-title":"Adherence to antiretroviral therapy among HIV-Infected adults in the United States","volume":"26","author":"L Beer","year":"2014","journal-title":"AIDS Educ Prev"},{"issue":"3","key":"pone.0262926.ref053","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1037\/hea0000310","article-title":"Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs","volume":"35","author":"WK Lee","year":"2016","journal-title":"Heal Psychol"},{"issue":"0 1","key":"pone.0262926.ref054","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/QAI.0000000000000577","article-title":"Barriers and facilitators to engagement of vulnerable populations in HIV Primary Care in New York City","volume":"69","author":"RH Remien","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"pone.0262926.ref055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/08870446.2015.1111371","article-title":"Medication beliefs and structural barriers to treatment adherence among people living with HIV infection","volume":"31","author":"S Kalichman","year":"2016","journal-title":"Psychol Heal"},{"issue":"6","key":"pone.0262926.ref056","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/09540120802513709","article-title":"Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV","volume":"21","author":"MS Friedman","year":"2009","journal-title":"AIDS Care\u2014Psychol Socio-Medical Asp AIDS\/HIV"},{"issue":"8","key":"pone.0262926.ref057","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s10461-017-1999-8","article-title":"Peer Support and the HIV Continuum of Care: Results from a Multi-Site Randomized Clinical Trial in Three Urban Clinics in the United States","volume":"22","author":"HJ Cabral","year":"2018","journal-title":"AIDS Behav"},{"issue":"8","key":"pone.0262926.ref058","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10461-011-9963-5","article-title":"Are Peer Interventions for HIV Efficacious? A Systematic Review","volume":"15","author":"JM Simoni","year":"2011","journal-title":"AIDS Behav"},{"issue":"6","key":"pone.0262926.ref059","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10461-013-0469-1","article-title":"Feasibility, acceptability and preliminary efficacy of an online peer-to-peer social support ART adherence intervention","volume":"17","author":"KJ Horvath","year":"2013","journal-title":"AIDS Behav"},{"issue":"1","key":"pone.0262926.ref060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J010v45n01_05","article-title":"Peer support to promote medication adherence among people living with HIV\/AIDS: The benefits to peers","volume":"45","author":"P Marino","year":"2007","journal-title":"Soc Work Health Care"},{"key":"pone.0262926.ref061","first-page":"26","volume-title":"Infectious Diseases of Poverty","author":"RA Salam","year":"2014"},{"issue":"2","key":"pone.0262926.ref062","first-page":"168","article-title":"Engaging community to support HIV prevention research","volume":"16","author":"S Sahay","year":"2011","journal-title":"East J Med"},{"key":"pone.0262926.ref063","volume-title":"Gates Open Research.","author":"S Reza-Paul","year":"2019"},{"issue":"11","key":"pone.0262926.ref064","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/apc.2018.0128","article-title":"Multi-Site Evaluation of Community-Based Efforts to Improve Engagement in HIV Care among Populations Disproportionately Affected by HIV in the United States","volume":"32","author":"A Raj","year":"2018","journal-title":"AIDS Patient Care STDS"},{"key":"pone.0262926.ref065","first-page":"859","volume-title":"American Journal of Public Health","author":"JE Myers","year":"2019"},{"issue":"2","key":"pone.0262926.ref066","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11524-006-9137-3","article-title":"Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990\u20132002: A model for effective service delivery to a high-risk population","volume":"84","author":"J Rothman","year":"2007","journal-title":"J Urban Heal"},{"key":"pone.0262926.ref067","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.socscimed.2016.03.028","article-title":"Medical mistrust among social network members may contribute to antiretroviral treatment nonadherence in African Americans living with HIV","volume":"164","author":"LM Bogart","year":"2016","journal-title":"Soc Sci Med"},{"issue":"6","key":"pone.0262926.ref068","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1475-6773.2009.01017.x","article-title":"Mistrust of health care organizations is associated with underutilization of health services","volume":"44","author":"TA Laveist","year":"2009","journal-title":"Health Serv Res"},{"issue":"SUPPL. 1","key":"pone.0262926.ref069","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1077558700057001S07","article-title":"Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients","volume":"57","author":"TA LaVeist","year":"2000","journal-title":"Med Care Res Rev"},{"issue":"7","key":"pone.0262926.ref070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1525-1497.2000.03359.x","article-title":"The doctor-patient relationship and HIV-infecfed patients\u2019 satisfaction with primary care physicians","volume":"15","author":"LM Sullivan","year":"2000","journal-title":"J Gen Intern Med"},{"issue":"1","key":"pone.0262926.ref071","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/apc.2019.0200","article-title":"Association of Medical Mistrust and Poor Communication with HIV-Related Health Outcomes and Psychosocial Wellbeing Among Heterosexual Men Living with HIV","volume":"34","author":"C Zhang","year":"2020","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"pone.0262926.ref072","first-page":"366","article-title":"Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investment","volume":"111","author":"BO Ojikutu","year":"2021"},{"issue":"4","key":"pone.0262926.ref073","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/25787489.2020.1824718","article-title":"Identifying appropriate candidates for long-acting antiretroviral therapy: findings from a survey of health care providers in the ATLAS-2M trial","volume":"21","author":"M Murray","year":"2020","journal-title":"HIV Res Clin Pract"},{"issue":"11","key":"pone.0262926.ref074","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1007\/s10461-019-02545-1","article-title":"HIV-Related Training and Correlates of Knowledge, HIV Screening and Prescribing of nPEP and PrEP Among Primary Care Providers in Southeast United States, 2017","volume":"23","author":"KD Henny","year":"2019","journal-title":"AIDS Behav"},{"issue":"6","key":"pone.0262926.ref075","article-title":"Provider training and experience for people living with HIV\/AIDS","author":"JM Rackal","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0262926.ref076","first-page":"e25541","volume-title":"Journal of the International AIDS Society","author":"BA Larson","year":"2020"},{"key":"pone.0262926.ref077","author":"M Roy","year":"1904","journal-title":"A Review of Differentiated Service Delivery for HIV Treatment: Effectiveness, Mechanisms, Targeting, and Scale"},{"issue":"Suppl 4","key":"pone.0262926.ref078","article-title":"Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa","volume":"20","author":"C Barker","year":"2017","journal-title":"J Int AIDS Soc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T18:46:13Z","timestamp":1643913973000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262926"}},"subtitle":[],"editor":[{"given":"Omar","family":"Sued","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":78,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0262926","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}